AIM ImmunoTech Files 8-K for Material Agreement
Ticker: AIM · Form: 8-K · Filed: Apr 4, 2025 · CIK: 946644
Sentiment: neutral
Topics: material-agreement, filing, biotech
TL;DR
AIM ImmunoTech signed a material deal, check the 8-K for details.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on April 4, 2025, reporting a material definitive agreement and financial statements. The filing pertains to the period ending April 1, 2025. The company is based in Ocala, Florida, and operates in the Biological Products sector.
Why It Matters
This 8-K filing indicates AIM ImmunoTech has entered into a significant agreement, which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.
Key Numbers
- 001-27072 — SEC File Number (Identifier for AIM ImmunoTech's filings)
- 52-0845822 — IRS Employer Identification No. (Tax identification for AIM ImmunoTech)
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- April 1, 2025 (date) — Earliest event reported
- April 4, 2025 (date) — Filing date
- 2117 SW Highway 484, Ocala FL 34473 (address) — Principal executive offices
- HEMISPHERX BIOPHARMA INC (company) — Former company name
FAQ
What is the nature of the material definitive agreement filed by AIM ImmunoTech?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 1, 2025.
What is AIM ImmunoTech Inc.'s principal executive office address?
The principal executive offices are located at 2117 SW Highway 484, Ocala FL 34473.
What was AIM ImmunoTech Inc. formerly known as?
The company was formerly known as HEMISPHERX BIOPHARMA INC.
What is the SIC code for AIM ImmunoTech Inc.?
The Standard Industrial Classification (SIC) code is 2836, for Biological Products (no diagnostic substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding AIM ImmunoTech Inc. (AIM).